| Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes AD Elmezayen, A Al-Obaidi, AT Şahin, K Yelekçi Journal of Biomolecular Structure and Dynamics 39 (8), 2980-2992, 2021 | 409 | 2021 |
| Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies G Bora-Tatar, D Dayangaç-Erden, AS Demir, S Dalkara, K Yelekçi, ... Bioorganic & medicinal chemistry 17 (14), 5219-5228, 2009 | 220 | 2009 |
| New pyrazoline bearing 4 (3H)-quinazolinone inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity N Gökhan-Kelekçi, S Koyunoğlu, S Yabanoğlu, K Yelekçi, Ö Özgen, ... Bioorganic & medicinal chemistry 17 (2), 675-689, 2009 | 190 | 2009 |
| Drug design for CNS diseases: polypharmacological profiling of compounds using cheminformatic, 3D-QSAR and virtual screening methodologies K Nikolic, L Mavridis, T Djikic, J Vucicevic, D Agbaba, K Yelekci, ... Frontiers in neuroscience 10, 265, 2016 | 88 | 2016 |
| A computational study on the amine-oxidation mechanism of monoamine oxidase: Insight into the polar nucleophilic mechanism SS Erdem, Ö Karahan, İ Yıldız, K Yelekçi Organic & biomolecular chemistry 4 (4), 646-658, 2006 | 83 | 2006 |
| Docking studies on monoamine oxidase-B inhibitors: Estimation of inhibition constants (Ki) of a series of experimentally tested compounds M Toprakçí, K Yelekçi Bioorganic & medicinal chemistry letters 15 (20), 4438-4446, 2005 | 71 | 2005 |
| Synthesis of some novel hydrazone and 2-pyrazoline derivatives: Monoamine oxidase inhibitory activities and docking studies B Evranos-Aksöz, S Yabanoğlu-Çiftçi, G Uçar, K Yelekçi, R Ertan Bioorganic & medicinal chemistry letters 24 (15), 3278-3284, 2014 | 65 | 2014 |
| Synthesis, molecular modeling, in vivo study, and anticancer activity of 1,2,4‐triazole containing hydrazide–hydrazones derived from (S)‐naproxen Mİ Han, H Bekçi, AI Uba, Y Yıldırım, E Karasulu, A Cumaoğlu, ... Archiv der Pharmazie 352 (6), 1800365, 2019 | 64 | 2019 |
| Histone Deacetylase Inhibition Activity and Molecular Docking of (E )‐Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy D Dayangaç‐Erden, G Bora, P Ayhan, C Kocaefe, S Dalkara, K Yelekci, ... Chemical biology & drug design 73 (3), 355-364, 2009 | 64 | 2009 |
| Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors N Gökhan-Kelekçi, ÖÖ Şimşek, A Ercan, K Yelekçi, ZS Şahin, Ş Işık, ... Bioorganic & medicinal chemistry 17 (18), 6761-6772, 2009 | 47 | 2009 |
| Electron spin resonance studies of monoamine oxidase B. First direct evidence for a substrate radical intermediate K Yelekci, X Lu, RB Silverman Journal of the American Chemical Society 111 (3), 1138-1140, 1989 | 45 | 1989 |
| Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: A combined approach of structure-based virtual screening, ADMET prediction and … AI Uba, K Yelekçi Journal of Biomolecular Structure and Dynamics 36 (12), 3231-3245, 2018 | 41 | 2018 |
| Observation of a flavin semiquinone in the resting state of monoamine oxidase B by electron paramagnetic resonance and electron nuclear double resonance spectroscopy VJ DeRose, JCG Woo, WP Hawe, BM Hoffman, RB Silverman, K Yelekci Biochemistry 35 (34), 11085-11091, 1996 | 41 | 1996 |
| New 2-pyrazoline and hydrazone derivatives as potent and selective monoamine oxidase A inhibitors U Salgin-Goksen, G Telli, A Erikci, E Dedecengiz, BC Tel, FB Kaynak, ... Journal of medicinal chemistry 64 (4), 1989-2009, 2021 | 38 | 2021 |
| Flavonoids from Sideritis Species: Human Monoamine Oxidase (hMAO) Inhibitory Activities, Molecular Docking Studies and Crystal Structure of Xanthomicrol FP Turkmenoglu, İ Baysal, S Ciftci-Yabanoglu, K Yelekci, H Temel, ... Molecules 20 (5), 7454-7473, 2015 | 38 | 2015 |
| cis‐cyclopropylamines as mechanism‐based inhibitors of monoamine oxidases T Malcomson, K Yelekci, MT Borrello, A Ganesan, E Semina, N De Kimpe, ... The FEBS Journal 282 (16), 3190-3198, 2015 | 37 | 2015 |
| Synthesis and screening of human monoamine oxidase‐A inhibitor effect of new 2‐pyrazoline and hydrazone derivatives B Evranos‐Aksöz, İ Baysal, S Yabanoğlu‐Çiftçi, T Djikic, K Yelekçi, ... Archiv der Pharmazie 348 (10), 743-756, 2015 | 35 | 2015 |
| Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties K Yelekci, Ö Karahan, M Toprakçı Journal of neural transmission 114, 725-732, 2007 | 34 | 2007 |
| Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors A Ibrahim Uba, K Yelekçi Journal of Biomolecular Structure and Dynamics 37 (14), 3627-3636, 2019 | 32 | 2019 |
| Synthesis, molecular docking and anticancer activity of diflunisal derivatives as cyclooxygenase enzyme inhibitors GP Coşkun, T Djikic, TB Hayal, N Türkel, K Yelekçi, F Şahin, ... Molecules 23 (8), 1969, 2018 | 30 | 2018 |
